Catalyst Wire Dossier Catalyst Wire Dossier

Subunit Trivalent Influenza Vaccine (Northern Hemisphere formulation 2013/2014)

Influenza vaccine, inactivated, subunit, trivalent · Novartis Vaccines
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Subunit Trivalent Influenza Vaccine (Northern Hemisphere formulation 2013/2014), covering 2014-03-12 to 2014-03-12. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Immunogenicity of a Subunit Trivalent Influenza Vaccine, Northern Hemisphere Formulation 2013/2014, in Healthy Adults Aged 18 Years and Above [Phase 2]

See pricing